Biopharmaceutical compositions
US12187791B2 · kind B2 · utility
0Cited by
22References
17Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Apr 30, 2024 |
| Grant date | Jan 7, 2025 |
| Priority date | — |
| Expiry date | Apr 30, 2044 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07K2317/94
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present disclosure relates to compositions for treating interleukin 5 (IL-5) mediated diseases, and related methods.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.